Erratum
for
Brizel et al., J Clin Oncol 18 (19) 3339-3345.
Journal of Clinical Oncology, Vol 18, Issue 24
(December), 2000: 4110-4111
© 2000 American Society for Clinical Oncology
Two appendices were omitted from the October 1, 2000, article by Brizel et al, entitled "Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer" (J Clin Oncol 18:3339-3345, 2000). The appendices are reprinted below in their entirity.
The November 1, 2000, Supplement article by Shepherd, entitled "Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Modest Progress, Many Choices" (J Clin Oncol 18:35s-38s, 2000 [suppl]), contained errors in the doses and results of Table 2. The correct dosage is 75 mg/m2 of docetaxel, not 100 mg/m2. The correct response rate is 17.3% for the docetaxel arm, not 7.3%. Table 2 is reprinted below in its entirety.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
|
